» Articles » PMID: 23820397

Streptomycin-induced Inflammation Enhances Escherichia Coli Gut Colonization Through Nitrate Respiration

Overview
Journal mBio
Specialty Microbiology
Date 2013 Jul 4
PMID 23820397
Citations 118
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Treatment with streptomycin enhances the growth of human commensal Escherichia coli isolates in the mouse intestine, suggesting that the resident microbial community (microbiota) can inhibit the growth of invading microbes, a phenomenon known as "colonization resistance." However, the precise mechanisms by which streptomycin treatment lowers colonization resistance remain obscure. Here we show that streptomycin treatment rendered mice more susceptible to the development of chemically induced colitis, raising the possibility that the antibiotic might lower colonization resistance by changing mucosal immune responses rather than by preventing microbe-microbe interactions. Investigation of the underlying mechanism revealed a mild inflammatory infiltrate in the cecal mucosa of streptomycin-treated mice, which was accompanied by elevated expression of Nos2, the gene that encodes inducible nitric oxide synthase. In turn, this inflammatory response enhanced the luminal growth of E. coli by nitrate respiration in a Nos2-dependent fashion. These data identify low-level intestinal inflammation as one of the factors responsible for the loss of resistance to E. coli colonization after streptomycin treatment.

Importance: Our intestine is host to a complex microbial community that confers benefits by educating the immune system and providing niche protection. Perturbation of intestinal communities by streptomycin treatment lowers "colonization resistance" through unknown mechanisms. Here we show that streptomycin increases the inflammatory tone of the intestinal mucosa, thereby making the bowel more susceptible to dextran sulfate sodium treatment and boosting the Nos2-dependent growth of commensal Escherichia coli by nitrate respiration. These data point to the generation of alternative electron acceptors as a by-product of the inflammatory host response as an important factor responsible for lowering resistance to colonization by facultative anaerobic bacteria such as E. coli.

Citing Articles

The molybdate transport protein ModA regulates nitrate reductase activity to increase the intestinal colonization and extraintestinal dissemination of in the inflamed gut.

Xie J, Wang H, Ma R, Fan J, Quan Q, Zhang Z Virulence. 2025; 16(1):2474185.

PMID: 40033924 PMC: 11901421. DOI: 10.1080/21505594.2025.2474185.


Comparison of Crohn's disease-associated adherent-invasive (AIEC) from France and Hong Kong: results from the Pacific study.

Chevarin C, Xu Z, Martin L, Robin F, Beyrouthy R, Colombel J Gut Microbes. 2024; 16(1):2431645.

PMID: 39587720 PMC: 11601055. DOI: 10.1080/19490976.2024.2431645.


Host-pathobiont interactions in Crohn's disease.

Caruso R, Lo B, Chen G, Nunez G Nat Rev Gastroenterol Hepatol. 2024; .

PMID: 39448837 DOI: 10.1038/s41575-024-00997-y.


The human gut microbiome in health and disease: time for a new chapter?.

Lee J, Bays D, Savage H, Baumler A Infect Immun. 2024; 92(11):e0030224.

PMID: 39347570 PMC: 11556149. DOI: 10.1128/iai.00302-24.


A New Real-Time Simple Method to Measure the Endogenous Nitrate Reductase Activity (Nar) in and Other Denitrifying Bacteria.

Garcia-Trejo J, Rojas-Alcantar S, Alonso-Vargas M, Ortega R, Benitez-Guzman A, Ramirez-Silva L Int J Mol Sci. 2024; 25(18).

PMID: 39337258 PMC: 11431489. DOI: 10.3390/ijms25189770.


References
1.
Wlodarska M, Willing B, Keeney K, Menendez A, Bergstrom K, Gill N . Antibiotic treatment alters the colonic mucus layer and predisposes the host to exacerbated Citrobacter rodentium-induced colitis. Infect Immun. 2011; 79(4):1536-45. PMC: 3067531. DOI: 10.1128/IAI.01104-10. View

2.
Keestra A, Godinez I, Xavier M, Winter M, Winter S, Tsolis R . Early MyD88-dependent induction of interleukin-17A expression during Salmonella colitis. Infect Immun. 2011; 79(8):3131-40. PMC: 3147556. DOI: 10.1128/IAI.00018-11. View

3.
Stecher B, Robbiani R, Walker A, Westendorf A, Barthel M, Kremer M . Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol. 2007; 5(10):2177-89. PMC: 1951780. DOI: 10.1371/journal.pbio.0050244. View

4.
Stojiljkovic I, Cobeljic M, Hantke K . Escherichia coli K-12 ferrous iron uptake mutants are impaired in their ability to colonize the mouse intestine. FEMS Microbiol Lett. 1993; 108(1):111-5. DOI: 10.1111/j.1574-6968.1993.tb06082.x. View

5.
Wadolkowski E, Laux D, Cohen P . Colonization of the streptomycin-treated mouse large intestine by a human fecal Escherichia coli strain: role of adhesion to mucosal receptors. Infect Immun. 1988; 56(5):1036-43. PMC: 259758. DOI: 10.1128/iai.56.5.1036-1043.1988. View